SENORES PHARMACEUTICALS LIMITED : BOARD MEETING OUTCOME

• Board approved appointment of Mrs. Shilpa Sharma as Company Secretary and Compliance Officer. • Board approved appointment of Mr. Viranchi Arvindbhai Shah as Non-Executive Additional Director (Independent Director). • Board approved the incorporation of a Wholly Owned Subsidiary (WOS) in Mexico. • Board approved the incorporation of a Subsidiary Company in Canada. • Board approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026 ("ESOS 2026"). • Meeting held on August 26, 2026, commenced at 04:45 P.M. (IST) and concluded at 05:15 P.M. (IST).

Senores Pharmaceuticals Limited

Open attachment

← Back to feed